Option Care Health, Inc. (OPCH)

NASDAQ: OPCH · USD

$31.3

-0.02 (-0.1%)· Recorded snapshot

Market cap	4.7B
Revenue (ttm)	5.7B
Net income (ttm)	209.6M
EPS (ttm)	$1.32
Shares out	149.8M
P/E (trailing)	23.7x
P/E (forward)	19.2x
Volume	1,802,722
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.7B
Net income (ttm): 209.6M
EPS (ttm): $1.32
P/E (trailing): 23.7x
P/E (forward): 19.2x
Market cap: 4.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.2

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE16

P25 n/aP50 n/aP75 n/a

ROIC10.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OPCH indicators

Market & fundamental data

Available fields

262

Groups with data

Currency

USD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001014739
Company name	Option Care Health, Inc.
Country	United States
Country code	US
CUSIP number	68404L201
Earnings date	2026-11-04
Earnings time	bmo
Employees	8,266
Employees change	178
Employees growth	2.2%
Enterprise value	$5.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
In index	RUSSELL2000
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US68404L2016
Last 10-K release date	2026-02-24
Last earnings date	2026-07-29
Last refreshed	2026-10-28
Last stock split date	2020-02-03
Last stock split type	Reverse
Market cap	$4.7B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$31.28
Price currency	USD
Sector	Healthcare
SIC code	8082
Stock price date	2026-10-28
Symbol	OPCH
U.S. state	Illinois
Website	https://optioncarehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	17.77x
Average P/E ratio (3Y)	22.3x
Average P/E ratio (5Y)	27.2x
Earnings yield	4.23%
EV/Earnings	27.48x
EV/EBIT	17.26x
EV/EBITDA	14.22x
EV/FCF	18.96x
EV/Sales	1.01x
FCF / EV yield	5.28%
FCF yield	6.48%
Forward EV/Sales	0.97x
Forward P/E	19.23x
Forward P/S	0.79x
Graham number	15.81715
Graham upside	-49.47%
Industry forward P/E	14.95x
Industry P/E	18.37x
Lynch fair value	$33.05
Lynch upside	5.58%
P/(FCF - SBC) ratio	17.7x
P/(OCF - SBC) ratio	15.23x
P/B ratio	3.72x
P/E ratio	23.66x
P/FCF ratio	15.43x
P/OCF ratio	13.52x
P/S ratio	0.82x
PEG ratio	2.05x
Price/EBITDA ratio	11.57x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.86%
EBITDA margin	7.12%
Effective tax rate	26.59%
FCF margin	5.34%
Gross margin	19.06%
Operating margin	5.86%
Pretax margin	5.01%
Profit margin	3.68%
Profit per employee	$25,354
Profitable quarters	21
Profitable years	5
Revenue per employee	$688,787
ROA	6.17%
ROA (5Y)	5.58%
ROCE	13.04%
ROE	16%
ROE (5Y)	14.75%
ROIC	10.27%
ROIC (5Y)	9.77%
SBC / revenue	0.69%
Tax / revenue	1.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.69%
EPS growth (Q)	12.9%
EPS growth (QoQ)	20.92%
EPS growth 3Y	0.09%
EPS growth 5Y	37.86%
EPS growth quarters	2
EPS growth years	1
FCF growth	25.99%
FCF growth (Q)	112.36%
FCF growth 3Y	-4.7%
FCF growth 5Y	16.49%
Gross profit growth	2.63%
Gross profit growth (Q)	-0.67%
Gross profit growth 3Y	5.32%
Gross profit growth 5Y	8.48%
Net income growth	-0.79%
Net income growth (Q)	6.71%
Net income growth (QoQ)	18.9%
Net income growth 3Y	-4.41%
Net income growth 5Y	34.03%
Net income growth quarters	1
Net income growth years	0
OCF growth	24.02%
OCF growth (Q)	103.24%
OCF growth 3Y	-3.83%
OCF growth 5Y	15.87%
Operating income growth	-0.1%
Operating income growth (Q)	2.94%
Operating income growth 3Y	6.29%
Operating income growth 5Y	16.41%
Revenue growth	5.95%
Revenue growth (Q)	1.86%
Revenue growth (QoQ)	6.79%
Revenue growth 3Y	11.27%
Revenue growth 5Y	12.17%
Revenue growth quarters	30
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-43M
Depreciation and amortization	$71.4M
EBIT	$333.7M
EBITDA	$405.1M
EPS	$1.32
FCF per share	$2.03
Financing cash flow	$-305.5M
Free cash flow	$303.8M
Free cash flow minus SBC	$264.8M
Gross profit	$1.1B
Income taxes	$75.9M
Investing cash flow	$-46.4M
Net borrowing	$44.1M
Net cash flow	$-5.1M
Net income	$209.6M
Operating cash flow minus SBC	$307.8M
Operating income	$333.7M
Revenue	$5.7B
Stock-based compensation	$39M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.84
Book value per share	$8.41
Debt / EBITDA	2.86
Debt / equity	1.01
Debt / FCF	4.17
Goodwill	$1.6B
Interest coverage	6.04
Long-term assets	$2.2B
Long-term liabilities	$1.3B
Net cash (debt)	$-1.1B
Net cash / market cap	-22.85%
Net debt / EBITDA	2.64
Net debt / equity	0.85
Net debt / FCF	3.53
Piotroski F-Score	5
Property, plant and equipment	$229.8M
Shareholders' equity	$1.3B
Tangible book value	$-637.5M
Tangible book value per share	$-4.26
Total assets	$3.4B
Total cash	$196.8M
Total debt	$1.3B
Total liabilities	$2.1B
WACC	6.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.68
Current assets	$1.2B
Current liabilities	$819.5M
Current ratio	1.47
Inventory turnover	11.48
Net working capital	$214.2M
Quick ratio	0.91
Working capital	$381.1M
Working capital turnover	14.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	5.7%
Dividend yield	0%
Shareholder yield	5.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$24.17
1D price change	-0.05%
1M price change	35.63%
1M total return	35.63%
1W price change	-0.22%
1W total return	-0.22%
1Y price change	12.39%
1Y return CAGR	12.4%
1Y total return	12.39%
20-day SMA	$29.93
200-day SMA	$26.36
3M price change	43.47%
3M total return	43.47%
3Y price change	17.5%
3Y return CAGR	5.52%
3Y total return	17.5%
50-day SMA	$26.17
50-day SMA vs 200-day SMA	50under200
52-week high	$36.80
52-week high date	2026-01-23
52-week low	$18.01
52-week low date	2026-04-30
5Y price change	17.46%
5Y return CAGR	3.27%
5Y total return	17.46%
6M price change	12.03%
6M total return	12.03%
All-time high	$36.80
All-time high date	2026-01-23
All-time low	$5.74
All-time low date	2020-03-18
Average true range (ATR)	$0.42
Average volume	7.3M
Beta (1Y)	0.56
Beta (2Y)	0.52
Beta (5Y)	0.58
Change from 52-week high	-15.01%
Change from 52-week low	73.65%
Change from all-time high	-14.97%
Change from all-time low	445.12%
Change from open	-0.08%
Day's gap	0.03%
Dollar volume	$56.4M
High price	$31.32
Low price	$31.26
Monthly RSI	55.76
Open price	$31.30
Position in 52-week range	25%
Premarket change	0.19%
Premarket close	$31.29
Premarket price	$31.35
Premarket volume	213
Previous close	$31.29
Price vs 150-day SMA	29.46%
Price vs 20-day SMA	4.54%
Price vs 200-day SMA	18.72%
Price vs 50-day SMA	19.55%
Relative volume	0.25
RSI	82.3
Sharpe ratio	0.4
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	0.21
Sortino ratio	0.77
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	0.44
Volume	1.8M
Weekly RSI	67.95
YTD price change	-1.79%
YTD total return	-1.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147.7M
Float percentage	98.61%
Shares change (QoQ)	-2.99%
Shares change (YoY)	-5.7%
Shares held by insiders	1.39%
Shares held by institutions	48.94%
Shares outstanding	149.8M
Short % of float	5.8%
Short % of shares	5.72%
Short ratio	4.1 days

Deeper analysis on OPCH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OPCH report

Is a complete OPCH research report available?

No complete published report is available for Option Care Health, Inc. (OPCH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Option Care Health, Inc. (OPCH)

Price

Financial snapshot

Fair-value bridge

Latest news · OPCH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OPCH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OPCH

Frequently asked questions